Macimorelin Completed Phase 3 Trials for Growth Hormone Deficiency With Pituitary Anomalies Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic3
clinicaltrials.gov IdentifierTitleDrugs
NCT02558829Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency